Mito-TEMPO, a Mitochondria-Targeted Antioxidant, Improves Cognitive Dysfunction due to Hypoglycemia: an Association with Reduced Pericyte Loss and Blood-Brain Barrier Leakage

Mol Neurobiol. 2023 Feb;60(2):672-686. doi: 10.1007/s12035-022-03101-0. Epub 2022 Nov 11.

Abstract

Hypoglycemia is associated with cognitive dysfunction, but the exact mechanisms have not been elucidated. Our previous study found that severe hypoglycemia could lead to cognitive dysfunction in a type 1 diabetes (T1D) mouse model. Thus, the aim of this study was to further investigate whether the mechanism of severe hypoglycemia leading to cognitive dysfunction is related to oxidative stress-mediated pericyte loss and blood-brain barrier (BBB) leakage. A streptozotocin T1D model (150 mg/kg, one-time intraperitoneal injection), using male C57BL/6J mice, was used to induce hypoglycemia. Brain tissue was extracted to examine for neuronal damage, permeability of BBB was investigated through Evans blue staining and electron microscopy, reactive oxygen species and adenosine triphosphate in brain tissue were assayed, and the functional changes of pericytes were determined. Cognitive function was tested using Morris water maze. Also, an in vitro glucose deprivation model was constructed. The results showed that BBB leakage after hypoglycemia is associated with excessive activation of oxidative stress and mitochondrial dysfunction due to glucose deprivation/reperfusion. Interventions using the mitochondria-targeted antioxidant Mito-TEMPO in both in vivo and in vitro models reduced mitochondrial oxidative stress, decreased pericyte loss and apoptosis, and attenuated BBB leakage and neuronal damage, ultimately leading to improved cognitive function.

Keywords: Blood-brain barrier; Cognitive dysfunction; Hypoglycemia; Mito-TEMPO; Oxidative stress; Pericyte.

MeSH terms

  • Animals
  • Antioxidants / metabolism
  • Antioxidants / pharmacology
  • Blood-Brain Barrier / metabolism
  • Cognitive Dysfunction* / complications
  • Cognitive Dysfunction* / drug therapy
  • Cognitive Dysfunction* / metabolism
  • Diabetes Mellitus, Type 1* / metabolism
  • Glucose / metabolism
  • Hypoglycemia* / complications
  • Hypoglycemia* / drug therapy
  • Hypoglycemia* / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mitochondria
  • Mitomycin / metabolism
  • Pericytes / metabolism

Substances

  • Antioxidants
  • Glucose
  • Mitomycin